Genotypes of Erythrovirus B19, Their Geographical Distribution & Circulation in Cases with Various Clinical Manifestations

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2018 Jun 21

PMID 29923512

Citations 6

Authors

Amita Jain

Ravi Kant

Affiliations

Soon will be listed here.

Abstract

Erythrovirus B19 (B19V) is one of the erythroviruses known to be pathogenic in humans. B19V is classified into three distinct genotypes; 1, 2 and 3, differing from each other by 2-13 per cent. Genotype 1 consists of the prototype B19V isolates, genotype 2 comprises the A6, LaLi and their related isolates while genotype 3 includes the V9- and V9-related isolates. The classification of genotype 1 into two subtypes (1A and 1B) and genotype 3 into two subtypes (3a and 3b) with an estimated nucleotide difference of about 5 per cent has been done. Predominance of genotype 1 across all the continents is seen followed by genotypes 2 and 3. There are no disease-specific genotypes. All the three genotypes have been found in symptomatic as well as asymptomatic individuals and have been reported from several countries across the world. The prevalence of genotype 2 in older populations and its absence from current circulation in Northern Europe has also been reported. The present review focuses on geographic distribution and association of genotypes of B19V with different clinical manifestations.

Citing Articles

Genotypic Characterization of Human Parvovirus B19 Circulating in the 2024 Outbreak in Tuscany, Italy.

Beligni G, Alessandri G, Cusi M Pathogens. 2025; 14(2).

PMID: 40005498 PMC: 11858505. DOI: 10.3390/pathogens14020121.

Seroepidemiology (2018-2024) and epidemic spread of an emerging human parvovirus B19 genotype 1 (subtype 1a2) variant in Hungary, 2023/2024.

Toth F, Moser T, Boros A, Balazs B, Takats K, Pankovics P Arch Virol. 2025; 170(2):45.

PMID: 39893614 PMC: 11788230. DOI: 10.1007/s00705-025-06228-2.

Reassessing the Risk of Severe Parvovirus B19 Infection in the Immunocompetent Population: A Call for Vigilance in the Wake of Resurgence.

Ceccarelli G, Branda F, Ciccozzi A, Romano C, Sanna D, Casu M Viruses. 2024; 16(9).

PMID: 39339829 PMC: 11435993. DOI: 10.3390/v16091352.

An Outbreak of Parvovirus B19 in Israel.

Patalon T, Saciuk Y, Trotzky D, Pachys G, Ben-Tov A, Segal Y Viruses. 2023; 15(11).

PMID: 38005937 PMC: 10674631. DOI: 10.3390/v15112261.

The epidemiological and genetic characteristics of human parvovirus B19 in patients with febrile rash illnesses in China.

Jiang H, Qiu Q, Zhou Y, Zhang Y, Xu W, Cui A Sci Rep. 2023; 13(1):15913.

PMID: 37741897 PMC: 10517975. DOI: 10.1038/s41598-023-43158-y.

References

Schneider B, Hone A, Tolba R, Fischer H, Blumel J, Eis-Hubinger A . Simultaneous persistence of multiple genome variants of human parvovirus B19. J Gen Virol. 2007; 89(Pt 1):164-176. DOI: 10.1099/vir.0.83053-0. View

He M, Zhu J, Yin H, Ke L, Gao L, Pan Z . Human immunodeficiency virus/human parvovirus B19 co-infection in blood donors and AIDS patients in Sichuan, China. Blood Transfus. 2012; 10(4):502-14. PMC: 3496238. DOI: 10.2450/2012.0134-11. View

Jain P, Jain A, Khan D, Kumar M . Human parvovirus B19 associated dilated cardiomyopathy. BMJ Case Rep. 2013; 2013. PMC: 3762240. DOI: 10.1136/bcr-2013-010410. View

Stewart G, Lopez-Molina J, Gottumukkala R, Rosner G, Anello M, Hecht J . Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure. Circ Heart Fail. 2010; 4(1):71-8. PMC: 3047418. DOI: 10.1161/CIRCHEARTFAILURE.110.958249. View

Cassinotti P, Burtonboy G, Fopp M, Siegl G . Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997; 53(3):229-32. View

Norja P, Hokynar K, Aaltonen L, Chen R, Ranki A, Partio E . Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A. 2006; 103(19):7450-3. PMC: 1464359. DOI: 10.1073/pnas.0602259103. View

Toan N, Duechting A, Kremsner P, Song L, Ebinger M, Aberle S . Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J Gen Virol. 2006; 87(Pt 10):2941-2949. DOI: 10.1099/vir.0.82037-0. View

Blumel J, Eis-Hubinger A, Stuhler A, Bonsch C, Gessner M, Lower J . Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells. J Virol. 2005; 79(22):14197-206. PMC: 1280213. DOI: 10.1128/JVI.79.22.14197-14206.2005. View

Ke L, He M, Li C, Liu Y, Gao L, Yao F . The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers. Transfusion. 2011; 51(9):1909-18. DOI: 10.1111/j.1537-2995.2011.03067.x. View

10.

Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet J . Genetic diversity within human erythroviruses: identification of three genotypes. J Virol. 2002; 76(18):9124-34. PMC: 136440. DOI: 10.1128/jvi.76.18.9124-9134.2002. View

11.

Hokynar K, Soderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio E . A new parvovirus genotype persistent in human skin. Virology. 2002; 302(2):224-8. DOI: 10.1006/viro.2002.1673. View

12.

Slavov S, Kashima S, Silva-Pinto A, Amarilla A, Aquino V, Covas D . Molecular and clinical evaluation of the acute human parvovirus B19 infection: comparison of two cases in children with sickle cell disease and discussion of the literature. Braz J Infect Dis. 2013; 17(1):97-101. PMC: 9427394. DOI: 10.1016/j.bjid.2012.06.026. View

13.

Porignaux R, Vuiblet V, Barbe C, NGuyen Y, Lavaud S, Toupance O . Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation. J Med Virol. 2013; 85(6):1115-21. DOI: 10.1002/jmv.23557. View

14.

Cotmore S, Agbandje-Mckenna M, Chiorini J, Mukha D, Pintel D, Qiu J . The family Parvoviridae. Arch Virol. 2013; 159(5):1239-47. PMC: 4013247. DOI: 10.1007/s00705-013-1914-1. View

15.

Nguyen Q, Wong S, Heegaard E, Brown K . Identification and characterization of a second novel human erythrovirus variant, A6. Virology. 2002; 301(2):374-80. DOI: 10.1006/viro.2002.1585. View

16.

Rahiala J, Koskenvuo M, Norja P, Meriluoto M, Toppinen M, Lahtinen A . Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013; 48(10):1308-12. DOI: 10.1038/bmt.2013.63. View

17.

Norja P, Eis-Hubinger A, Soderlund-Venermo M, Hedman K, Simmonds P . Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections. J Virol. 2008; 82(13):6427-33. PMC: 2447064. DOI: 10.1128/JVI.00471-08. View

18.

da Costa A, Bendit I, de Oliveira A, Kallas E, Sabino E, Sanabani S . Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities. Clin Microbiol Infect. 2012; 19(1):E31-E43. DOI: 10.1111/1469-0691.12058. View

19.

Tolfvenstam T, Ruden U, Broliden K . Evaluation of serological assays for identification of parvovirus B19 immunoglobulin M. Clin Diagn Lab Immunol. 1996; 3(2):147-50. PMC: 170264. DOI: 10.1128/cdli.3.2.147-150.1996. View

20.

Eis-Hubinger A, Reber U, Glatzel U, Lauschke H, Putz U . Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol. 2001; 65(2):395-401. DOI: 10.1002/jmv.2047. View